Researchers from Eotvos Lorand University Report on Findings in Cancer [Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates].

Keywords: Amphibian Venoms; Biological Factors; Bombesin; Cancer; Cancer Therapy; Cell Surface Receptors; Drug Conjugates; Drug Development; Drugs and Therapies; Gastrin-Releasing Peptides; Gastrointestinal Hormones; Health and Medicine; Membrane Proteins; Neuropeptides; Oncology; Peptide Hormones; Peptide Proteins; Peptide Receptors; Peptides; Proteins; Proteomics EN Amphibian Venoms Biological Factors Bombesin Cancer Cancer Therapy Cell Surface Receptors Drug Conjugates Drug Development Drugs and Therapies Gastrin-Releasing Peptides Gastrointestinal Hormones Health and Medicine Membrane Proteins Neuropeptides Oncology Peptide Hormones Peptide Proteins Peptide Receptors Peptides Proteins Proteomics 1124 1124 1 03/23/23 20230317 NES 230317 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on cancer are discussed in a new report. Amphibian Venoms, Biological Factors, Bombesin, Cancer, Cancer Therapy, Cell Surface Receptors, Drug Conjugates, Drug Development, Drugs and Therapies, Gastrin-Releasing Peptides, Gastrointestinal Hormones, Health and Medicine, Membrane Proteins, Neuropeptides, Oncology, Peptide Hormones, Peptide Proteins, Peptide Receptors, Peptides, Proteins, Proteomics. [Extracted from the article]